This year’s event will specifically focus on innovations within the field that has the potential to drive the pharmaceutical industry into a new era of medicines, with optimization of the R&D process to become cheaper, faster and increasing the likelihood of drug efficacy and success. These are some of the major obstacles within drug discovery at present, as the process is overall long, expensive and often potential drugs will fail late in clinical trials, wasting resources and time.
Topics: Drug Discovery, drug development, drug design, drug discovery conference, pharmaceutical, artificial intelligence, artificial intelligence in pharma, structure based discovery, Medicinal Chemistry, Chemistry, AI, ADMET, chemistry